Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Do Not Edit

2 clinical trials in Do Not Edit, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Do Not Edit at a glance
2
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Do Not Edit

Open in trial search

Glomerulonephritis chronic

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Region Oestergoetland

Spinal muscular atrophy

Not yet recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:BIIB115
  • Sponsor:Biogen Idec Research Limited

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Do Not Edit

What the registry says about research in the country

01 Do Not Edit
Immune System Diseases
Clinical investigations in the city are concentrating on ANCA-associated vasculitis, aiming to clarify how long patients can stay off therapy without risking disease return. Relapse rate after stopping rituximab Comparison with continuous rituximab maintenance Outcomes in patients who have achieved stable remission Impact on long‑term safety and quality of life The trial seeks to inform clinicians whether a drug holiday is feasible, potentially reducing treatment burden while maintaining disease control.
Nervous System Diseases
A second study focuses on Spinal Muscular Atrophy, evaluating the safety of adding salanersen after early gene therapy with onasemnogene abeparvovec. Safety and tolerability of combination therapy Effects on motor function in infants Monitoring for immune responses to the gene vector Long‑term developmental outcomes By studying babies who received presymptomatic treatment, researchers hope to improve therapeutic strategies for this severe neuromuscular disorder.
Musculoskeletal Diseases
While current trials do not directly target musculoskeletal conditions, the research environment is poised to expand into related areas such as inflammatory joint disease and bone health. Potential integration of immune‑modulating agents Exploration of biomarkers for disease activity Collaboration opportunities with orthopedic specialists Ongoing recruitment and a dedicated investigator suggest that future studies may soon address unmet needs in musculoskeletal health.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.